Ad
ADMA Quote Trading Chart ADMA Biologics Inc
home / stock / adma / adma quote
$2.37 Last:
9.72% Change Percent:
$2.27 Open:
$2.16 Previous Close:
$2.455 High:
$2.25 Low:
4,609,085 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
ADMA Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-08-12 | 2.27 | 2.16 | 2.455 | 2.25 | 4,609,085 |
| 2022-08-11 | 2.13 | 2.16 | 2.48 | 2.09 | 6,409,464 |
| 2022-08-10 | 2.06 | 2.16 | 2.12 | 1.99 | 1,700,908 |
| 2022-08-09 | 2.05 | 2.16 | 2.09 | 1.97 | 2,435,467 |
| 2022-08-08 | 2.13 | 2.16 | 2.18 | 2.05 | 2,170,948 |
| 2022-08-05 | 2.08 | 2.16 | 2.215 | 2.08 | 1,244,521 |
| 2022-08-04 | 2.11 | 2.16 | 2.16 | 2.07 | 1,472,977 |
| 2022-08-03 | 2.11 | 2.16 | 2.1275 | 2.08 | 1,054,307 |
| 2022-08-02 | 2.03 | 2.16 | 2.11 | 2.03 | 791,396 |
| 2022-08-01 | 2.13 | 2.16 | 2.1399 | 2.01 | 1,399,154 |
| 2022-07-29 | 2.17 | 2.16 | 2.17 | 2.07 | 1,565,532 |
| 2022-07-28 | 2.16 | 2.16 | 2.19 | 2.07 | 2,115,221 |
| 2022-07-26 | 2.16 | 2.16 | 2.205 | 2.1201 | 357,975 |
| 2022-07-25 | 2.16 | 2.19 | 2.2 | 2.11 | 991,637 |
| 2022-07-19 | 2.14 | 2.17 | 2.21 | 2.115 | 954,982 |
| 2022-07-18 | 2.33 | 2.09 | 2.33 | 2.04 | 3,559,522 |
| 2022-07-15 | 2.26 | 2.3 | 2.38 | 2.18 | 3,827,865 |
| 2022-07-14 | 2.22 | 2.22 | 2.265 | 2.18 | 1,535,423 |
| 2022-07-13 | 2.18 | 2.27 | 2.305 | 2.18 | 1,513,576 |
| 2022-07-12 | 2.22 | 2.24 | 2.26 | 2.19 | 1,595,604 |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
ADMA Biologics (NASDAQ: ADMA) , typically one of the more under-the-radar coronavirus stocks, was very much on the radar of many investors on Thursday. The company's shares popped by over 5% on an otherwise generally flat day for stocks in general, thanks to an estimates-beating sec...
-
Shares of ADMA Biologics Inc (NASDAQ:ADMA) traded today at $2.48, eclipsing its 52-week high. So far today approximately 253,000 shares have been exchanged, as compared to an average 30-day volume of 1.8 million shares. ADMA Biologics Inc is an end-to-end commercial biopharmaceutical com...
-
2Q2022 Total Revenues Were $33.9 Million, a 90% Y-o-Y Increase Grew 2Q2022 Gross Profit to $7.8 Million, Up 112% Over 1Q2022 Narrowed 2Q2022 Net Losses to $13.8 Million, a 45% Improvement Over 1Q2022 Full Year 2022 Total Revenues Expected to Exceed $130 Million ...